neospect
cis bio international - депретид трифлуороацетат - Радиоюклидно изображение - Диагностични радиофармацевтици - Този лекарствен продукт е само за диагностична употреба. За сцинтиграфических изображения подозирали злокачествени тумори в белите дробове, след първоначалното откриване, в съчетание с компютърна ТОМОГРАФИЯ или рентгенография на гръдния кош, при пациенти с солитарными легочными поредици.
ceprotin
takeda manufacturing austria ag - човешки протеин С - purpura fulminans; protein c deficiency - Антитромботични агенти - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
mycapssa
amryt pharmaceuticals dac - octreotide acetate - акромегалия - Хипофизни и хипоталамични хормони и аналози - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
octreotide lyomark 0,1 mg/ml solution for injection
lyomark pharma gmbh - Октреотид - 0,1 mg/ml solution for injection
octreotide lyomark 0,05 mg/ml solution for injection
lyomark pharma gmbh - Октреотид - 0,05 mg/ml solution for injection
octreotide csc 500 micrograms/ml solution for injection
gp pharm, s.a. - 500 micrograms/ml solution for injection
octreotide csc 100 micrograms/ml solution for injection
gp pharm, s.a. - 100 micrograms/ml solution for injection
octreotide csc 50 micrograms/ml solution for injection
gp pharm, s.a. - 50 micrograms/ml solution for injection
octreotide lai teva 20 mg powder and solvent for prolonged - release suspension for injection
20 mg powder and solvent for prolonged - release suspension for injection
octreotide lai teva 30 mg powder and solvent for prolonged - release suspension for injection
30 mg powder and solvent for prolonged - release suspension for injection